9 Myths About Surgical Menopause That Leave Women Undertreated and Overwhelmed
The women who reach out after a bilateral oophorectomy often describe the same thing: waking up from surgery feeling fine, then within days being hit by a wave of symptoms nobody warned them about. What breaks my heart is how many of them were told this was normal and to give it time — when what they actually needed was urgent, tailored hormonal support. Surgical menopause deserves its own conversation, not the leftovers of one written for someone else.
Learn more about Rose →Myth: Surgical Menopause Is Just Like Natural Menopause, Only Earlier
Natural menopause unfolds over a perimenopause transition that can span four to ten years, during which estrogen and progesterone decline gradually and the body has time to adapt. Surgical menopause caused by bilateral oophorectomy removes the primary source of estrogen and testosterone in a single day, creating an abrupt hormonal cliff rather than a slope. Research consistently shows that women with surgical menopause report more severe vasomotor symptoms, greater mood disruption, and faster bone density loss than women who transition naturally at the same age.
Myth: Hormone Therapy Is Optional for Women After Oophorectomy
For women who reach natural menopause in their early fifties, hormone therapy is a treatment choice to be weighed against individual risk. For women who undergo oophorectomy before the natural age of menopause, the evidence points firmly toward hormone therapy as the standard of care, not an elective extra. Premature loss of estrogen is independently associated with increased cardiovascular disease risk, accelerated bone loss, cognitive decline, and all-cause mortality — risks that HRT has been shown to meaningfully reduce in this population.
Myth: The Hot Flashes Will Peak and Then Settle Down Quickly
Women entering natural menopause often find that vasomotor symptoms — hot flashes and night sweats — peak around the final menstrual period and then gradually ease. In surgical menopause, the estrogen drop is so sudden that the hypothalamus, which regulates body temperature and has its thermostat calibrated by estrogen, can be thrown into sustained dysregulation. Studies show women with surgical menopause frequently experience more frequent and more intense vasomotor symptoms, and without hormonal support those symptoms can persist far longer than the typical natural menopause arc.
Myth: Mental Health Changes Are Psychological, Not Hormonal
Anxiety, low mood, emotional volatility, and even depressive episodes after oophorectomy are often attributed to the stress of surgery or an underlying mental health condition. In reality, estrogen plays a direct role in serotonin and dopamine synthesis and receptor sensitivity, meaning its sudden absence has immediate neurochemical consequences. Women who undergo premenopausal oophorectomy have a statistically elevated risk of depression and anxiety compared to those who retain their ovaries, a difference that hormonal support substantially reduces.
Myth: Testosterone Doesn't Matter Because Women Don't Need Much of It
The ovaries produce roughly half of a woman's testosterone, so bilateral oophorectomy effectively cuts testosterone levels in half almost immediately. Testosterone in women supports libido, energy, muscle mass, bone density, and cognitive sharpness — none of which are trivial. Women after oophorectomy frequently describe a flattening of motivation, significant loss of sexual desire, and physical fatigue that estrogen therapy alone does not fully resolve, pointing to the distinct and under-acknowledged role of testosterone replacement in this group.
Myth: Bone Loss Isn't an Urgent Concern Until Later in Life
Estrogen is the primary brake on osteoclast activity — the cellular process that breaks down bone — and its abrupt removal accelerates bone resorption at a rate that outpaces anything seen in natural menopause. Women who undergo oophorectomy before 45 have substantially higher lifetime fracture risk than those who enter menopause naturally, and bone loss begins immediately after surgery rather than gradually. Waiting years before considering bone density monitoring or intervention in this group means missing the window when protective action is most effective.
Myth: Brain Fog After Surgery Is Just Anesthesia Wearing Off
It is reasonable to expect some cognitive fuzziness in the days following any major surgery involving general anesthesia. But the memory lapses, word retrieval problems, and concentration difficulties that persist weeks or months after oophorectomy are driven by estrogen withdrawal, not lingering anesthetic effects. Estrogen receptors are densely distributed across the hippocampus and prefrontal cortex — the regions most involved in memory and executive function — and their sudden deprivation disrupts synaptic signaling in measurable, documented ways.
Myth: Genitourinary Symptoms Are Minor and Can Wait
Vaginal dryness, thinning of vaginal tissue, painful intercourse, and urinary urgency are grouped under the umbrella term genitourinary syndrome of menopause, and they can begin within weeks of oophorectomy. Unlike hot flashes, which often diminish over time even without treatment, genitourinary symptoms are progressive — the tissue changes are permanent if untreated, and symptoms worsen rather than improve with time. Local vaginal estrogen therapy is highly effective, carries minimal systemic absorption, and is considered safe even for many women who cannot take systemic HRT.
Myth: Lifestyle Changes Are Enough to Manage Surgical Menopause
Exercise, sleep hygiene, dietary adjustments, and stress management are genuinely valuable tools in managing menopause symptoms at any stage — but they work by supporting a body that is in gradual hormonal transition, not one that has experienced a sudden total loss of ovarian hormones. Recommending lifestyle changes as a primary intervention for surgical menopause is a bit like recommending hydration after a significant blood loss: not wrong in principle, but a wholly inadequate response to the scale of what has happened. For most women under 45 who have undergone bilateral oophorectomy, evidence-based guidelines from major menopause societies explicitly support hormonal therapy as the foundational treatment, with lifestyle measures as a complement rather than a substitute.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.